Skip to content
value.today

Johnson & Johnson vs OptiNose, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $135 M for OptiNose, Inc., 4833 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for OptiNose, Inc.). OptiNose, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $49 M for OptiNose, Inc. in the year to December 2020.
  • Johnson & Johnson made a net profit of $26.8 B, while OptiNose, Inc. made a net loss of $100 M.
  • Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -203.1% for OptiNose, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

043851281702020202120222023202420252026Johnson & Johnson 170OptiNose, Inc. 34

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B20182019202020212022202320242025Johnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureJohnson & Johnson
JNJ · #23 in the world
OptiNose, Inc.
OPTN
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded18862010
Size
Market cap$652.5 B$135 M*
Revenue$94.2 B$49 M
Net income$26.8 B▲ best$-100 M
Employees138,200—
Valuation
P/E ratio40.5×—
Price to sales6.6×—
Price to book8.0×—
Free cash flow yield3.0%—
Altman Z-score zone——
Data as ofMarket cap Oct 2026Market cap Jan 2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Johnson & Johnson or OptiNose, Inc.?

Johnson & Johnson is the larger company by market value: $652.5 B against $135 M for OptiNose, Inc., 4833 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for OptiNose, Inc.). OptiNose, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Johnson & Johnson or OptiNose, Inc.?

Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $49 M for OptiNose, Inc. in the year to December 2020. Johnson & Johnson made a net profit of $26.8 B, while OptiNose, Inc. made a net loss of $100 M.

Which is more profitable, Johnson & Johnson or OptiNose, Inc.?

Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -203.1% for OptiNose, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.